Actualités de Germany

Filtre
  • 23.06.2020 – 15:58

    IgNova GmbH

    IgNova files patent application on antibody against COVID-19

    Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...

  • 28.05.2020 – 10:00

    Merck Healthcare Germany

    Merck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS

    Darmstadt, Germany (ots/PRNewswire) - - Merck and Twitch collaborate on World MS Day to increase understanding of the impact of multiple sclerosis (MS) - Livestream event with Twitch influencers on May 30 will raise awareness and money for the MS International Federation and help connect people affected by the disease, in line with official World MS Day theme MS ...

  • 26.05.2020 – 16:14

    DERMALOG Identification Systems GmbH

    DERMALOG Fever Check at German Baltic Hotel

    Usedom and Hamburg, Germany (ots/PRNewswire) - - Picture is available at AP Images ( http://www.apimages.com/ ) - In the course of the Corona pandemic, the hospitality industry has come under increased scrutiny by public authorities. Incidents such as the Covid-19 outbreak in the Austrian town of Ischgl have led to extensive regulations for the safe operation of hotels and restaurants. At the same time, owners are ...

  • 14.05.2020 – 00:23

    Merck Healthcare Germany

    Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020

    Darmstadt, Germany (ots/PRNewswire) - - Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, biomarker and HRQoL analyses for tepotinib?, the first MET inhibitor to have received a regulatory approval for NSCLC with MET gene alterations - Two-year follow-up for first-in-class bifunctional immunotherapy bintrafusp alfa? ...

  • 30.04.2020 – 14:00

    Merck Healthcare Germany

    Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care

    Darmstadt, Germany and New York (ots/PRNewswire) - - Not intended for US-, Canada- or UK-based media - ASCO Abstract # BAVENCIO® (avelumab): LBA1, 5061; Bintrafusp alfa (bifunctional fusion protein): 9558; Tepotinib (MET kinase inhibitor): 9556, 9575. - Late-breaking presentation of Phase III JAVELIN Bladder 100 data for BAVENCIO® showing overall survival benefit in ...

  • 05.09.2019 – 09:15

    Quantron AG

    Innovation Company Quantron AG Sets New Standards in the Field of E-mobility

    Augsburg, Germany (ots/PRNewswire) - Founded in July, the company offers innovative e-mobility solutions in the truck sector, giving companies a sustainable and economic dimension through a corresponding range of retrofitting processes. QuantronAG offers logistics, bus and municipal disposal companies for MAN, Mercedes, DAF and Iveco brands, as well as a range of ...

  • 08.08.2019 – 10:13

    iPoint-systems gmbh

    iPoint Welcomes Dr. Bing Xu as Director of Market Engagement

    Xu brings to iPoint 25 years of management experience at Ford Reutlingen, Germany (ots/PRNewswire) - iPoint is proud to welcome Dr. Bing Xu as Director of Market Engagement In this newly-created function, Dr. Xu will be responsible for helping customers leverage iPoint's applications for product and process compliance, and sustainability. Based in Ann Arbor at the North America main office, he will focus on the benefits ...

  • 11.07.2019 – 08:10

    Gerresheimer AG

    Gerresheimer Reports Strong Second Quarter

    - Revenues up 7.2% on the prior-year quarter to EUR 356.5m - Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from derecognition of contingent purchase price compo­nents in connection with Sensile Medical acquisition - Revenue guidance confirmed without change; guidance on adjusted EBITDA at constant exchange rates for the financial year 2019 approximately EUR 295m (plus ...

  • 01.07.2019 – 00:01

    emoji Company GmbH

    emoji® Signs Licensing Agreement With The Hershey Company

    Hamburg, Germany (ots/PRNewswire) - The emoji company has entered into a licensing agreement with The Hershey Company with regard to emoji company's registered emoji® trademark. The agreement covers the Hershey's brand launch of a limited edition Hershey's Milk Chocolate Emoji Bar this summer. The product will be available nationwide throughout summer 2019. The Hershey's Milk Chocolate Emoji Bar will feature 25 different ...

  • 24.06.2019 – 14:00

    Merck Healthcare Germany

    Merck to Showcase New Data Across MS Portfolio at EAN 2019

    Not intended for UK or U.S. based media Darmstadt, Germany (ots/PRNewswire) - - Company to present 16 abstracts on MAVENCLAD® (cladribine tablets), Rebif® (interferon beta-1a) and investigational evobrutinib at the 5th Congress of the European Academy of Neurology - Presentations include new data on the long-term efficacy and safety of MAVENCLAD®, new safety data for Rebif® and the 48-week analysis from the Phase 2 ...